Iterum Therapeutics plc ITRM 深 沪
已收盘 03-27 16:00:00 美东时间
0.0356
-0.140
-79.77%
华盛通- 最 高0.086
- 今 开0.03
- 成交量 9404.49万股
- 最 低 0.0271
- 昨 收 0.176
- 总市值 189.72万
- 52周最高 1.42
- 市盈率 静 --
- 换手率 176.47%
- 52周最低 0.0271
- 委 比 99.34%
- 总股本 5329.16万
- 历史最高 195.00
- 量 比 255.68
- 振 幅 33.47%
- 历史最低 0.0271
- 每 手 1
- 风险率 0.32%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Iterum Therapeutics Initiates Liquidation Proceedings and Leadership Exit
Iterum Therapeutics ( ($ITRM) ) has issued an announcement. On March 27, 2026, ...
今天 01:56
Iterum Therapeutics Submits Petition In Ireland's High Court To Wind Up Operations
Iterum Therapeutics plc (in Provisional Liquidation) (Nasdaq: ITRM) (the "Company" or "Iterum" or "we"), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug
03-27 21:31
Iterum Therapeutics Announces Filing of Winding Up Petition
Iterum Therapeutics plc has filed a petition in Ireland's High Court to wind up its company due to limited cash resources, inability to raise additional capital, failure to regain NASDAQ listing compliance, and high operational expenses. The company may withdraw its drug ORLYNVAH™ from the U.S. market. The liquidation process is expected to result in dissolution of the company and its subsidiaries.
03-27 13:25
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Edesa Biotech (NASDAQ:EDSA) shares rose 61.0% to $3.67 during Tuesday'...
03-04 01:05
Why Ouster Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Shares of Ouster Inc (NASDAQ:OUST) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued first-quar
03-03 18:27
Iterum Therapeutics Faces Nasdaq Delisting, Weighs Strategic Options
Iterum Therapeutics ( ($ITRM) ) just unveiled an update. On February 24, 2026, ...
03-03 07:12
Iterum Therapeutics Reaches Rebate Milestone, Obtains Patent
ITRM reaches another signed rebate agreement with one of the top three Medicare Part D Pharmacy Benefit Managers;Iterum has been granted a patent in the United States that covers a bilayer tablet comprising
02-13 21:05
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Jasper Therapeutics (NASDAQ:JSPR) stock rose 19.6% to $1.4 during Frid...
02-13 20:05
Iterum Therapeutics Provides Business Update
<p align="center"><em>Expanded Market Access & Patent Protection for ORLYNVAH™</em></p> <p>DUBLIN and CHICAGO, Feb. 13, 2026 — Iterum Therapeutics plc announced updates on market access, patent protection, and FDA correspondence for ORLYNVAH™. The company secured a rebate agreement with a top Medicare Part D Pharmacy Benefit Manager, expanding access to over 3.5 million people. A new U.S. patent was granted for ORLYNVAH™, expiring in 2039, and ...
02-13 13:00
Iterum Therapeutics Provides Business Update
Iterum Therapeutics plc provided a business update, highlighting recent developments including expanded market access for ORLYNVAH™ through a major PBM agreement, covering over 40 million lives starting in early 2026, and the expansion of its patent estate with a Japanese patent grant for sulopenem etzadroxil, probenecid, and valproic acid combination, projected to expire in March 2041. The company remains optimistic about securing additional pay...
2025-12-17 13:00
